Sana Biotechnology, Inc.
SANA
$3.55
-$0.12-3.27%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -5.97% | -5.94% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 29.55% | -28.04% | |||
| Operating Income | -29.55% | 28.04% | |||
| Income Before Tax | -34.79% | 19.75% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -34.79% | 19.75% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -34.79% | 19.75% | |||
| EBIT | -29.55% | 28.04% | |||
| EBITDA | -31.98% | 28.43% | |||
| EPS Basic | -26.22% | 20.03% | |||
| Normalized Basic EPS | -21.39% | 24.22% | |||
| EPS Diluted | -26.22% | 20.03% | |||
| Normalized Diluted EPS | -21.39% | 24.22% | |||
| Average Basic Shares Outstanding | 6.79% | 0.35% | |||
| Average Diluted Shares Outstanding | 6.79% | 0.35% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||